Realm Therapeutics (NASDAQ:RLM) is currently exploring strategic alternatives.

The Investing Policy, which remains the strategic focus of the Directors, requires the Company to seek to invest in, partner with, acquire and/or be acquired by a company with meaningful development potential in the life sciences sector or with good overall business prospects; or, if a suitable transaction is not identified, the Company will consider winding down and distributing the remaining assets to Shareholders, following satisfaction of applicable obligations.


Company Presentation

More information is coming soon.

Company Presentation

More information is coming soon.

Search Investor Relations